JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.
Right arrow Articles by Fang, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.
Right arrow Articles by Fang, W.

Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial 99mTc-MIBI SPECT and 18F-FDG PET

Xiaoli Zhang, Xiu-Jie Liu, Qingyu Wu, Rongfang Shi, Ronglin Gao, Yunzhong Liu, Shengshou Hu, Yueqin Tian, Shaoxian Guo and Wei Fang

Departments of Nuclear Medicine, Surgery, and Cardiology, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China



View larger version (49K):

[in a new window]
 
FIGURE 1. 99mTc-MIBI SPECT and FDG PET images of patient with MI. (A) Perfusion–metabolism MM at apex, anterior, septal, and inferoposterior walls (arrows) before revascularization. (B) After CABG, perfusion defects of segments improved significantly and size of left ventricle decreased. EF increased from 30% to 42%. ST = stress; RE = rest.

 


View larger version (33K):

[in a new window]
 
FIGURE 2. 99mTc-MIBI SPECT (A) and FDG PET (B) images of patient with MI show perfusion–metabolism M in inferoposterior wall (arrows) before revascularization. (C) After CABG, perfusion defects did not improve and EF did not change (38% vs. 39%).

 


View larger version (29K):

[in a new window]
 
FIGURE 3. Changes of EF (%) and EDD (mm) at baseline (Pre), 3 mo (Pos1), and 6 mo (Pos2) after revascularization in groups A1 and B1.

 


View larger version (12K):

[in a new window]
 
FIGURE 4. Cumulative cardiac event-free survival curves of groups A1 and A2 (A) and groups B1 and B2 (B). RVS = revascularization; Med = medical therapy.

 


View larger version (13K):

[in a new window]
 
FIGURE 5. Cumulative survival curves of groups A1 and A2 (A) and groups B1 and B2 (B). RVS = revascularization; Med = medical therapy.

 


View larger version (12K):

[in a new window]
 
FIGURE 6. Cumulative cardiac event-free survival curves of patients with aneurysm and viable myocardium (A) and patients with aneurysm and no viable myocardium (B). RVS = revascularization; Med = medical therapy.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.